These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18267967)

  • 1. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.
    Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T
    Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional domains in p53 family proteins exhibit both common and distinct properties.
    Harms KL; Chen X
    Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
    [No Abstract]   [Full Text] [Related]  

  • 3. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
    Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
    Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
    Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
    Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox state of p63 and p73 core domains regulates sequence-specific DNA binding.
    Tichý V; Navrátilová L; Adámik M; Fojta M; Brázdová M
    Biochem Biophys Res Commun; 2013 Apr; 433(4):445-9. PubMed ID: 23501101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and p73 display common and distinct requirements for sequence specific binding to DNA.
    Lokshin M; Li Y; Gaiddon C; Prives C
    Nucleic Acids Res; 2007; 35(1):340-52. PubMed ID: 17170001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cadmium, cobalt and nickel on sequence-specific DNA binding of p63 and p73 in vitro and in cells.
    Adámik M; Bažantová P; Navrátilová L; Polášková A; Pečinka P; Holaňová L; Tichý V; Brázdová M
    Biochem Biophys Res Commun; 2015 Jan; 456(1):29-34. PubMed ID: 25446071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
    van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
    Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for ASPP2 recognition by the tumor suppressor p73.
    Canning P; von Delft F; Bullock AN
    J Mol Biol; 2012 Nov; 423(4):515-27. PubMed ID: 22917970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.
    Pivonková H; Pecinka P; Cesková P; Fojta M
    FEBS J; 2006 Oct; 273(20):4693-706. PubMed ID: 16981908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
    Zhang L; Nie L; Maki CG
    Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?
    Zawacka-Pankau J; Kostecka A; Sznarkowska A; Hedström E; Kawiak A
    Cell Cycle; 2010 Feb; 9(4):720-8. PubMed ID: 20160513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.
    Tozluoğlu M; Karaca E; Haliloglu T; Nussinov R
    Nucleic Acids Res; 2008 Sep; 36(15):5033-49. PubMed ID: 18660513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.
    Ethayathulla AS; Nguyen HT; Viadiu H
    J Biol Chem; 2013 Feb; 288(7):4744-54. PubMed ID: 23243311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
    Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
    Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.